CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Iloperidone

伊潘立酮 杂质对照品Iloperidone Impurities

43 个杂质条目43 impurity entries

本页汇总 伊潘立酮 的 43 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 43 impurity reference standards of Iloperidone. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 伊潘立酮(Iloperidone)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesIdentification of stress degradation products of iloperidone using liquid chromatography coupled with an Orbitrap mass spectrometer
    Rapid communications in mass spectrometry : RCM · 2017 · Pandeti S et al.  ·  PMID 28556266  ·  DOI
  2. 分析方法Analytical MethodsSimultaneous determination of iloperidone and its metabolites in rat plasma using a novel UPLC-MS/MS method: an application for drug-drug interaction
    BMC pharmacology & toxicology · 2025 · Chen X et al.  ·  PMID 41291928  ·  DOI
  3. 分析方法Analytical MethodsSimultaneous determination of iloperidone and its two active metabolites in human plasma by liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2013 · Jia M et al.  ·  PMID 23618742  ·  DOI
  4. 分析方法Analytical MethodsStable-isotope dilution LC-MS/MS assay for determination of iloperidone and its two major metabolites, P 88 and P 95, in human plasma: application to a bioequivalence study
    Bioanalysis · 2013 · Parekh JM et al.  ·  PMID 23484785  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisFlow Synthesis in Hot Water: Synthesis of the Atypical Antipsychotic Iloperidone
    Chemistry (Weinheim an der Bergstrasse, Germany) · 2016 · Hartwig J, Kirschning A  ·  PMID 26808334  ·  DOI

伊潘立酮 —— 原料药与杂质对照品Iloperidone — drug substance & impurities

共 44 个条目(含原料药本体)44 items incl. the drug substance
Iloperidone structure
原料药 APIAPI
伊潘立酮Iloperidone
Iloperidone
CAS No.133454-47-4
Chemical FormulaC24H27FN2O4
Purity>95%询价On request
10mg25mg50mg100mg
Iloperidone Impurity 3 Hydrochloride structure
3
伊潘立酮杂质3 盐酸盐Iloperidone Impurity 3 Hydrochloride
Iloperidone Impurity 3 Hydrochloride
CAS No.84163-16-6
Chemical FormulaC12H14ClFN2O
Purity>95%询价On request
10mg25mg50mg100mg
Iloperidone Impurity 3 structure
3
伊潘立酮杂质3Iloperidone Impurity 3
Iloperidone Impurity 3
CAS No.84163-64-4
Chemical FormulaC12H13FN2O
Purity>95%询价On request
10mg25mg50mg100mg
Iloperidone Impurity 4 Hydrochloride structure
4
伊潘立酮杂质4 盐酸盐Iloperidone Impurity 4 Hydrochloride
Iloperidone Impurity 4 Hydrochloride
CAS No.84163-22-4
Chemical FormulaC12H15ClN2O
Purity>95%询价On request
10mg25mg50mg100mg
Iloperidone Impurity 4 structure
4
伊潘立酮杂质4Iloperidone Impurity 4
Iloperidone Impurity 4
CAS No.84163-68-8
Chemical FormulaC12H14N2O
Purity>95%询价On request
10mg25mg50mg100mg
Iloperidone Impurity 5 structure
5
伊潘立酮杂质5Iloperidone Impurity 5
Iloperidone Impurity 5
CAS No.531524-17-1
Chemical FormulaC24H25FN4O2
Purity>95%询价On request
10mg25mg50mg100mg
Iloperidone Impurity 6 structure
6
伊潘立酮杂质6Iloperidone Impurity 6
Iloperidone Impurity 6
CAS No.2379325-11-6
Chemical FormulaC24H25F2N3O2
Purity>95%询价On request
10mg25mg50mg100mg
Iloperidone Impurity 8 structure
8
伊潘立酮杂质8Iloperidone Impurity 8
Iloperidone Impurity 8
CAS No.1016743-93-3
Chemical FormulaC12H13F2NO
Purity>95%询价On request
10mg25mg50mg100mg
Iloperidone Impurity 8 Hydrochloride structure
8
伊潘立酮杂质8 盐酸盐Iloperidone Impurity 8 Hydrochloride
Iloperidone Impurity 8 Hydrochloride
CAS No.1172297-96-9
Chemical FormulaC12H14ClF2NO
Purity>95%询价On request
10mg25mg50mg100mg
Iloperidone Impurity 9 Hydrochloride structure
9
伊潘立酮杂质9 盐酸盐Iloperidone Impurity 9 Hydrochloride
Iloperidone Impurity 9 Hydrochloride
CAS No.64671-29-0
Chemical FormulaC12H14FNO·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Iloperidone Impurity 9 structure
9
伊潘立酮杂质9Iloperidone Impurity 9
Iloperidone Impurity 9
CAS No.98294-54-3
Chemical FormulaC12H14FNO
Purity>95%询价On request
10mg25mg50mg100mg
Iloperidone Impurity 10 structure
10
伊潘立酮杂质10Iloperidone Impurity 10
Iloperidone Impurity 10
CAS No.170170-50-0
Chemical FormulaC24H28FNO5
Purity>95%询价On request
10mg25mg50mg100mg
Iloperidone Impurity 11 structure
11
伊潘立酮杂质11Iloperidone Impurity 11
Iloperidone Impurity 11
CAS No.133454-76-9
Chemical FormulaC24H28FN3O3
Purity>95%询价On request
10mg25mg50mg100mg
Iloperidone Impurity 12 structure
12
伊潘立酮杂质12Iloperidone Impurity 12
Iloperidone Impurity 12
CAS No.475110-48-6
Chemical FormulaC23H25FN2O5
Purity>95%询价On request
10mg25mg50mg100mg
Iloperidone Impurity 13 structure
13
伊潘立酮杂质13Iloperidone Impurity 13
Iloperidone Impurity 13
CAS No.1375651-09-4
Chemical FormulaC24H27FN2O5
Purity>95%询价On request
10mg25mg50mg100mg
Iloperidone Impurity 14 structure
14
伊潘立酮杂质14Iloperidone Impurity 14
Iloperidone Impurity 14
CAS No.133454-46-3
Chemical FormulaC24H28N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Iloperidone Impurity 15 structure
15
伊潘立酮杂质15Iloperidone Impurity 15
Iloperidone Impurity 15
CAS No.501373-88-2
Chemical FormulaC24H29FN2O4
Purity>95%询价On request
10mg25mg50mg100mg
Iloperidone Impurity 16 structure
16
伊潘立酮杂质16Iloperidone Impurity 16
Iloperidone Impurity 16
CAS No.501373-87-1
Chemical FormulaC24H29FN2O4
Purity>95%询价On request
10mg25mg50mg100mg
Iloperidone Impurity 17 structure
17
伊潘立酮杂质17Iloperidone Impurity 17
Iloperidone Impurity 17
CAS No.170170-48-6
Chemical FormulaC24H27FN2O5
Purity>95%询价On request
10mg25mg50mg100mg
Iloperidone Impurity 19 structure
19
伊潘立酮杂质19Iloperidone Impurity 19
Iloperidone Impurity 19
CAS No.58113-30-7
Chemical FormulaC12H15ClO3
Purity>95%询价On request
10mg25mg50mg100mg
Iloperidone Impurity 20  Monomer structure
20
伊潘立酮杂质20单体Iloperidone Impurity 20 Monomer
Iloperidone Impurity 20 Monomer
CAS No.691007-07-5
Chemical FormulaC12H14F2N2O
Purity>95%询价On request
10mg25mg50mg100mg
Iloperidone Impurity 21 structure
21
伊潘立酮杂质21Iloperidone Impurity 21
Iloperidone Impurity 21
CAS No.1388072-44-3
Chemical FormulaC12H13F2NO
Purity>95%询价On request
10mg25mg50mg100mg
Iloperidone Impurity 21 Hydrochloride structure
21
伊潘立酮杂质21 盐酸盐Iloperidone Impurity 21 Hydrochloride
Iloperidone Impurity 21 Hydrochloride
CAS No.1558734-83-0
Chemical FormulaC12H13F2NO·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Iloperidone Impurity 23 structure
23
伊潘立酮杂质23Iloperidone Impurity 23
Iloperidone Impurity 23
CAS No.3245-49-6
Chemical FormulaC12H15BrO3
Purity>95%询价On request
10mg25mg50mg100mg
Iloperidone Impurity 26 structure
26
伊潘立酮杂质26Iloperidone Impurity 26
Iloperidone Impurity 26
CAS No.1375651-23-2
Chemical FormulaC36H39FN4O5
Purity>95%询价On request
10mg25mg50mg100mg
Iloperidone Impurity 28 structure
28
伊潘立酮杂质28Iloperidone Impurity 28
Iloperidone Impurity 28
CAS No.1487957-15-2
Chemical FormulaC14H20O4
Purity>95%询价On request
10mg25mg50mg100mg
Iloperidone Impurity 31 structure
31
伊潘立酮杂质31Iloperidone Impurity 31
Iloperidone Impurity 31
CAS No.116218-80-5
Chemical FormulaC12H14O3
Purity>95%询价On request
10mg25mg50mg100mg
Iloperidone Impurity 37 structure
37
伊潘立酮杂质37Iloperidone Impurity 37
Iloperidone Impurity 37
CAS No.204781-71-5
Chemical FormulaC9H10O3
Purity>95%询价On request
10mg25mg50mg100mg
Iloperidone Impurity 48 structure
48
伊潘立酮杂质48Iloperidone Impurity 48
Iloperidone Impurity 48
CAS No.133455-04-6
Chemical FormulaC25H29FN2O4
Purity>95%询价On request
10mg25mg50mg100mg
Iloperidone Impurity 50 structure
50
伊潘立酮杂质50Iloperidone Impurity 50
Iloperidone Impurity 50
CAS No.792857-93-3
Chemical FormulaC12H15Cl2NO
Purity>95%询价On request
10mg25mg50mg100mg
Iloperidone Impurity 55 structure
55
伊潘立酮杂质55Iloperidone Impurity 55
Iloperidone Impurity 55
CAS No.84162-86-7
Chemical FormulaC12H13F2NO
Purity>95%询价On request
10mg25mg50mg100mg
Iloperidone Impurity 58 structure
58
伊潘立酮杂质58Iloperidone Impurity 58
Iloperidone Impurity 58
CAS No.691007-05-3
Chemical FormulaC12H14F2N2O
Purity>95%询价On request
10mg25mg50mg100mg
Iloperidone Impurity 58 Acetate structure
58
伊潘立酮杂质58 醋酸盐Iloperidone Impurity 58 Acetate
Iloperidone Impurity 58 Acetate
CAS No.691007-06-4
Chemical FormulaC12H14F2N2O·n(C2H4O2)
Purity>95%询价On request
10mg25mg50mg100mg
Iloperidone Impurity 59 structure
59
伊潘立酮杂质59Iloperidone Impurity 59
Iloperidone Impurity 59
CAS No.1206185-12-7
Chemical FormulaC12H13FN2O
Purity>95%询价On request
10mg25mg50mg100mg
Iloperidone Impurity 60 Hydrochloride structure
60
伊潘立酮杂质60 盐酸盐Iloperidone Impurity 60 Hydrochloride
Iloperidone Impurity 60 Hydrochloride
CAS No.95742-19-1
Chemical FormulaC12H13FN2O·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Iloperidone Impurity 60 structure
60
伊潘立酮杂质60Iloperidone Impurity 60
Iloperidone Impurity 60
CAS No.95742-20-4
Chemical FormulaC12H13FN2O
Purity>95%询价On request
10mg25mg50mg100mg
Iloperidone Impurity 61 structure
61
伊潘立酮杂质61Iloperidone Impurity 61
Iloperidone Impurity 61
CAS No.767582-67-2
Chemical FormulaC12H14FNO2
Purity>95%询价On request
10mg25mg50mg100mg
Iloperidone Impurity 63 structure
63
伊潘立酮杂质63Iloperidone Impurity 63
Iloperidone Impurity 63
CAS No.1797883-91-0
Chemical FormulaC24H29FN2O5
Purity>95%询价On request
10mg25mg50mg100mg
Iloperidone Impurity 64 structure
64
伊潘立酮杂质64Iloperidone Impurity 64
Iloperidone Impurity 64
CAS No.1309041-89-1
Chemical FormulaC19H22O6S
Purity>95%询价On request
10mg25mg50mg100mg
Iloperidone Impurity 65 structure
65
伊潘立酮杂质65Iloperidone Impurity 65
Iloperidone Impurity 65
CAS No.81055-36-9
Chemical FormulaC10H13BrO3S
Purity>95%询价On request
10mg25mg50mg100mg
Iloperidone Impurity 66 structure
66
伊潘立酮杂质66Iloperidone Impurity 66
Iloperidone Impurity 66
CAS No.64603-90-3
Chemical FormulaC6H9NO2
Purity>95%询价On request
10mg25mg50mg100mg
Iloperidone Impurity 66 Hydrochloride structure
66
伊潘立酮杂质66 盐酸盐Iloperidone Impurity 66 Hydrochloride
Iloperidone Impurity 66 Hydrochloride
CAS No.68547-97-7
Chemical FormulaC6H9NO2·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Iloperidone Impurity 68 Hydrochloride structure
68
伊潘立酮杂质68 盐酸盐Iloperidone Impurity 68 Hydrochloride
Iloperidone Impurity 68 Hydrochloride
CAS No.140235-26-3
Chemical FormulaC12H13F2NO·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Iloperidone Impurity 68 structure
68
伊潘立酮杂质68Iloperidone Impurity 68
Iloperidone Impurity 68
CAS No.149452-43-7
Chemical FormulaC12H13F2NO
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

伊潘立酮 —— 研究文献与合成路线Iloperidone — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 伊潘立酮 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Iloperidone. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Identification of stress degradation products of iloperidone using liquid chromatography coupled with an Orbitrap mass spectrometer
    Pandeti S, Rout TK, Tadigoppula N, et al. · Rapid communications in mass spectrometry : RCM · 2017 · 被引 7cited 7
  2. Method for determining related substance of Iloperidone through high-performance liquid chromatography
    XIA GUO, SHUHUI MOU · 2010

合成与制备工艺专利Synthesis & process patents

  1. AN IMPROVED PROCESS FOR PREPARING ILOPERIDONE
    RAMAN JAYARAMAN VENKAT, RANE DNYANDEV, KEVAT JITENDRA, PATIL DATTATRAY · 公开号 WO2011154860WO2011154860 · 2011
  2. AN IMPROVED PROCESS FOR THE PREPARATION OF ILOPERIDONE
    REGURI BUCHI REDDY, ARUNAGIRI MUTHULINGAM, YARROJU PRASADA CHARI, KASIYAPPAN GURUSAMY SARAVANAKUMAR, et al. · 公开号 WO2011055188WO2011055188 · 2011
  3. PROCESS FOR THE PREPARATION OF ILOPERIDONE
    VERTESSY MIKLOS · 公开号 US2010076196US2010076196 · 2010
  4. NEW PROCESS FOR THE PREPARATION OF ILOPERIDONE
    MIKLOS VERTESSY · 公开号 WO2010031497WO2010031497 · 2010
  5. PROCESS FOR THE PREPARATION OF ILOPERIDONE USING A NOVEL INTERMEDIATE
    MOHAN RAO DODDA, KRISHNA REDDY PINGILI, CHANDANA REDDY KANAKUNTLA, RIZWANA MOHAMMAD · 公开号 WO2011061750WO2011061750 · 2011

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

伊潘立酮 杂质谱研究要点Iloperidone — impurity profiling notes

下面这些是拿到 伊潘立酮 的 44 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 44 impurity entries for Iloperidone, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances